This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Rocket Stocks to Buy in February


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

As the largest life insurer in the U.S., MetLife (MET - Get Report) has a pretty stolid business. Insurance isn't that exciting, but sometimes, boring is better for your portfolio.

MetLife may be the biggest insurer here at home, but the firm has growth at its fingertips in overseas markets. With operations in more than 50 countries, MetLife has exposure to currencies and economies that are much better positioned to swell in size -- particularly if the U.S. dollar starts to slump on an exodus from treasuries. Latin America is an especially attractive market for MetLife right now, and management knows it - the region makes up around half of the countries that MET operates in.

Here at home, the commoditization of the insurance business has made profitability more challenging. That said, MET's size provides a big advantage. Because MetLife can underwrite business that smaller insurer's don't have the scale to dump on their balance sheets, the firm has an operational advantage in an industry where advantages are few and far between.

MetLife is another financial firm that became a bank holding company in the height of the financial crisis, but the firm is trying to shed that status. Management has been selling off its banking assets for the past few years, decreasing its exposure to Europe, and working on gaining approval from regulators. Once that happens, MET will look more attractive to investors.
5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
DIS $104.93 1.22%
GS $159.53 -0.34%
MET $42.81 -1.68%
PCLN $1,240.85 -0.97%
RL $91.00 -2.20%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs